{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:06:28Z","timestamp":1768734388002,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.carrev.2023.10.020","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:08:28Z","timestamp":1698970108000},"page":"70-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dynamic changes in inflammatory responses and 3-year clinical outcomes of XINSORB scaffolds in coronary stenting"],"prefix":"10.1016","volume":"61","author":[{"given":"Shushu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2023.10.020_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2023.10.020_bb0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.167.2.174","article-title":"Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis","volume":"167","author":"Ranjit","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.carrev.2023.10.020_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yexmp.2018.01.008","article-title":"Potential of anti-inflammatory agents for treatment of atherosclerosis","volume":"104","author":"Chistiakov","year":"2018","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2023.10.020_bb0025","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcin.2017.09.037","article-title":"A randomized trial comparing the NeoVas Sirolimus-eluting bioresorbable scaffold and metallic Everolimus-eluting stents","volume":"11","author":"Han","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.10.020_bb0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ccd.28067","article-title":"Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: one-year results from a prospective patient-level pooled analysis of NeoVas trials","volume":"93","author":"Xu","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.10.020_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10554-018-1326-0","article-title":"Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes","volume":"34","author":"Lv","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2023.10.020_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2019.06.053","article-title":"Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease","volume":"293","author":"Wu","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mhj.2003.16","article-title":"Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease","volume":"145","author":"Almagor","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0055","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjcard.2006.03.039","article-title":"Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent","volume":"98","author":"Karha","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2006.07.059","article-title":"Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris","volume":"99","author":"Gach","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0065","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.4244\/EIJ-D-19-00865","article-title":"Biodegradable polymer-coated versus durable polymer-coated sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial","volume":"16","author":"Xu","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2023.10.020_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0080","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1253\/circj.CJ-12-0801","article-title":"Inflammation and vascular injury: basic discovery to drug development","volume":"76","author":"Simon","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0090","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.10.020_bb0095","doi-asserted-by":"crossref","first-page":"1042329","DOI":"10.1155\/2020\/1042329","article-title":"Drug-coated balloons versus Everolimus-eluting stents in patients with in-stent restenosis: a pair-wise meta-analysis of randomized trials","volume":"2020","author":"Peng","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.carrev.2023.10.020_bb0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00380-018-1281-7","article-title":"Immune-inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective","volume":"34","author":"Kozel","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carrev.2023.10.020_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MCA.0000000000000699","article-title":"Association between inflammatory biomarkers and neointimal response following elective implantation of the ABSORB bioresorbable vascular scaffold","volume":"30","author":"Rampat","year":"2019","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2023.10.020_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00011-019-01269-1","article-title":"Regulation of C-reactive protein conformation in inflammation","volume":"68","author":"Yao","year":"2019","journal-title":"Inflamm Res"},{"key":"10.1016\/j.carrev.2023.10.020_bb0120","first-page":"4","article-title":"Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice","volume":"2","author":"Ridker","year":"2004","journal-title":"Am Heart Hosp J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0125","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1161\/01.CIR.0000148986.52696.07","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper","volume":"110","author":"Roberts","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2023.10.020_bb0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1253\/circj.69.1477","article-title":"Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting","volume":"69","author":"Hong","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.12659\/MSM.908692","article-title":"Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: a clinical trial based on 1-year follow-up","volume":"25","author":"Cheng","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.carrev.2023.10.020_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.004981","article-title":"White blood cell count and major adverse cardiovascular events after percutaneous coronary intervention in the contemporary era: insights from the PARIS study (patterns of non-adherence to anti-platelet regimens in stented patients registry)","volume":"10","author":"Shah","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2023.10.020_bb0145","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V91.6.2005","article-title":"Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice","volume":"91","author":"Ploplis","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.carrev.2023.10.020_bb0150","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2016.02.032","article-title":"Effect of serum fibrinogen, total stent length, and type of acute coronary syndrome on 6-month major adverse cardiovascular events and bleeding after percutaneous coronary intervention","volume":"117","author":"Mahmud","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ihj.2015.06.006","article-title":"Periprocedural plasma fibrinogen levels and coronary stent outcome","volume":"67","author":"Kavitha","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0160","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.12659\/MSM.906838","article-title":"Effects of tumor necrosis factor \u03b1 (TNF-\u03b1) and Interleukina 10 (IL-10) on intercellular cell adhesion molecule-1 (ICAM-1) and cluster of differentiation 31 (CD31) in human coronary artery endothelial cells","volume":"24","author":"Xue","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.carrev.2023.10.020_bb0165","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jcmm.12923","article-title":"Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-\u03b1 mediated NF-\u03baB pathway","volume":"20","author":"Gao","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.carrev.2023.10.020_bb0170","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1096\/fj.05-4634com","article-title":"Tumor necrosis factor-alpha plays an important role in restenosis development","volume":"19","author":"Monraats","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0175","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12872-021-02406-7","article-title":"The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients","volume":"21","author":"Ling","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2023.10.020_bb0185","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carrev.2023.10.020_bb0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2023.10.020_bb0195","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2023.10.020_bb0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2023.10.020_bb0205","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2023.10.020_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.carrev.2012.10.006","article-title":"The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions","volume":"14","author":"Zimarino","year":"2013","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2023.10.020_bb0215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10554-020-02073-3","article-title":"Inflammation as a determinant of healing response after coronary stent implantation","volume":"37","author":"Ochijewicz","year":"2021","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892300862X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892300862X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T06:27:16Z","timestamp":1711520836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892300862X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S155383892300862X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.10.020","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes in inflammatory responses and 3-year clinical outcomes of XINSORB scaffolds in coronary stenting","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}